Search

everythinglearnresearchcommunity

for

Search:↓

New hair regrowth model proposed, imiquimod found to kill skin cancer cells, T-cadherin loss linked to invasive skin cancer, no clear gene link to skin cancer after transplant, and study on children's hair loss shows male dominance and genetic ties.

The Yorkshire terrier has a genetic hair loss condition not improved by treatment.

CCCA and LPP may be related hair loss conditions influenced by genetics and environment, needing early treatment.

AAG causes hair loss in many people, with limited treatments like finasteride, minoxidil, light therapy, and hair transplants.

AGA is a genetic, hormonal hair loss treated with finasteride, minoxidil, and supplements, but new compounds are being developed.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

Current treatments for common male hair loss have limited effectiveness and can cause side effects.

Hair loss and excessive growth treated with various options, including new laser technology.

A rare ovarian tumor was found in a young woman with a genetic fat disorder.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Early diagnosis and treatment can help manage hair loss effectively.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Certain herbs can help reduce hair loss.

Familial frontal fibrosing alopecia is rare, mostly affects women, and often occurs between sisters or mother-daughter pairs.

PCOS is a common condition in women that can lead to infertility and other health issues, and it's diagnosed by specific criteria with various treatment options available.

Hair loss from alopecia areata and androgenetic alopecia can be treated, but more effective and safer treatments are needed.

Minoxidil was promising for treating male and female pattern baldness in 1994, but more research on genetics and other treatments was needed.

Androgenetic alopecia is influenced by multiple genes and pathways, with genetic risk varying by population, and personalized treatments are being explored.

Finasteride and minoxidil are effective, low-risk treatments for male hair loss, and patient education on these therapies is important.

Men with high genetic risk for Polycystic Ovary Syndrome (PCOS) have increased chances of obesity, type 2 diabetes, heart disease, and hair loss, showing PCOS risk factors can affect both genders.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Topical Imiquimod may fight vascular tumors by affecting blood vessels or the immune system, low iron might be linked to some hair loss, removing the top skin layer helps vitamin C get in, genetic testing helps diagnose skin conditions, and too much iron could worsen skin inflammation.

Women with hair loss have more androgen receptors in certain hair follicles.

No link found between aromatase gene and female hair loss.

Aryl hydrocarbon receptor overexpression found in miniaturized hair follicles in female hair loss.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Higher levels of MiR-92a-1-5p and miR-328-3p found in female hair loss patients.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

Use "female pattern hair loss" term, finasteride may help, more research needed.

Six new hair loss factors in men not linked to female hair loss.